First they treated diabetes. Then obesity. Now GLP-1 drugs (https://www.economist.com/leaders/2024/10/24/its-not-just-obesity-drugs-like-ozempic-will-change-the-world?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term=sa.listeners) are being tested on a range of other diseases too. Though the US economy (https://www.economist.com/leaders/2024/10/17/americas-economy-is-bigger-and-better-than-ever?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term=sa.listeners) is roaring, many Americans are glum about its prospects. How could that affect the election (9:02)? And our podcast on why Chinese migrants (https://www.economist.com/interactive/china/2024/10/08/how-to-escape-from-china-to-america?utm_campaign=a.io&utm_medium=audio.podcast.np&utm_source=theintelligence&utm_content=discovery.content.anonymous.tr_shownotes_na-na_article&utm_term=sa.listeners) are making perilous journeys through the jungle to reach America (16:55).
Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+ (https://subscribenow.economist.com/podcasts-plus)
For more information about how to access Economist Podcasts+, please visit our FAQs page (https://myaccount.economist.com/s/article/What-is-Economist-Podcasts) or watch our video (https://www.youtube.com/watch?v=Gczo71bg1uY) explaining how to link your account.
Hosted on Acast. See acast.com/privacy (https://acast.com/privacy) for more information.